<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Aileron Snags $40M From Quartet of Pharma Giants to Develop New Class of Drugs</title>
	<atom:link href="http://www.xconomy.com/boston/2009/06/08/aileron-snags-40m-from-quartet-of-pharma-giants-to-develop-new-class-of-drugs/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/boston/2009/06/08/aileron-snags-40m-from-quartet-of-pharma-giants-to-develop-new-class-of-drugs/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sun, 22 Nov 2009 23:52:13 -0600</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Pure Science Play: Pharma Venture Arms Believe in Aileron, $40M in Series D &#124; IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Research, Humor and Updates on the Latest Events in Biotech and Pharma - Unique, Insightful, Truthful, Sometimes S</title>
		<link>http://www.xconomy.com/boston/2009/06/08/aileron-snags-40m-from-quartet-of-pharma-giants-to-develop-new-class-of-drugs/comment-page-1/#comment-64253</link>
		<dc:creator>Pure Science Play: Pharma Venture Arms Believe in Aileron, $40M in Series D &#124; IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Research, Humor and Updates on the Latest Events in Biotech and Pharma - Unique, Insightful, Truthful, Sometimes S</dc:creator>
		<pubDate>Mon, 08 Jun 2009 13:55:40 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=28292#comment-64253</guid>
		<description>[...] out Pharmalive or Xconomy for [...]</description>
		<content:encoded><![CDATA[<p>[...] out Pharmalive or Xconomy for [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
